ITeos Therapeutics Inc (ITOS)

27.38 +0.03  +0.11% NASDAQ Oct 22, 16:00 27.42 +0.04  +0.15% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All ITOS News

News

View All Events

Events

Date Type Description
05/13/2022 16:33 EST Earnings Calls Q1 2022 Earnings Call
11/12/2021 Earnings Results Q3 2021 Earnings Results
08/12/2021 Earnings Results Q2 2021 Earnings Results
08/12/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/16/2021 11:00 EST AGM 2020 Annual General Meeting
05/13/2021 Earnings Results Q1 2021 Earnings Results
05/13/2021 16:33 EST Earnings Calls Q1 2021 Earnings Call
03/24/2021 Earnings Results Q4 2020 Earnings Results
11/12/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.
  • URL: https://www.iteostherapeutics.com
  • Investor Relations URL: https://investors.iteostherapeutics.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Aug. 12, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.